Colorectal Cancer

CURE spoke with Michael J. Overman, M.D. about the promise of anti-PD-1 therapy for patients with MSI-H colorectal cancer.

Before passing away from colorectal cancer, Cindy Stowell won over $100,000 in "Jeopardy!" and donated the money toward cancer research.

Opdivo is showing benefit for patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC), according to a recent trial.

A recent trial found that a four-drug regimen showed improved survival for patients with advanced colorectal cancer.

A recent study found that frequent, moderate exercise may reduce mortality and progression in patients with metastatic colorectal cancer.

CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.

Patients with metastatic colorectal cancer now have more treatment options than ever, explains Tanios Bekaii-Saab, M.D.

The National LGBT Cancer Network is making cancer screenings more available to a high-risk, underserved population.

In colorectal and other cancers, financial burden is worsened by expensive drugs, long-term treatment and sharing of insurance costs.

While colorectal cancer on the left side may have a survival benefit, the stage of the cancer may pay an important role.

Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for Hispanic men, rates have remained essentially unchanged. A new study suggests that lower rates of screening may be the driver of this disparity.

Volker Heinemann says early tumor shrinkage may be a better predictor than progression-free survival in colorectal cancer.

CURE spoke with Axel Grothey about advances in the treatment of colorectal cancer.

A wide-range of colon cancer screening options will be available and insured for patients, thanks to recent USPSTF recommendations.

The combination of Opdivo and Yervoy showed promise for certain patients with colorectal cancer in a phase 2 study.